Legal Limbo: Genmab’s ofatumumab SPC dilemma heads to CJEU
The Metropolitan Court of Hungary (Fővárosi Törvényszék) has referred a new question to the Court of Justice of the EU (CJEU) about the requirements for obtaining supplementary protection certificates (SPCs). Joel Beevers explains what we know so far in this emergent case.